Solid Biosciences Inc (SLDB)
8.94
-0.36
(-3.87%)
USD |
NASDAQ |
May 17, 16:00
8.94
0.00 (0.00%)
After-Hours: 20:00
Solid Biosciences Total Assets (Quarterly): 164.94M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 164.94M |
| September 30, 2023 | 184.73M |
| June 30, 2023 | 204.72M |
| March 31, 2023 | 229.59M |
| December 31, 2022 | 260.25M |
| September 30, 2022 | 184.47M |
| June 30, 2022 | 208.50M |
| March 31, 2022 | 207.56M |
| December 31, 2021 | 232.38M |
| September 30, 2021 | 248.99M |
| June 30, 2021 | 265.86M |
| March 31, 2021 | 285.28M |
| December 31, 2020 | 171.17M |
| September 30, 2020 | 40.52M |
| Date | Value |
|---|---|
| June 30, 2020 | 57.96M |
| March 31, 2020 | 73.96M |
| December 31, 2019 | 103.47M |
| September 30, 2019 | 130.93M |
| June 30, 2019 | 96.30M |
| March 31, 2019 | 120.23M |
| December 31, 2018 | 139.60M |
| September 30, 2018 | 156.81M |
| June 30, 2018 | 171.47M |
| March 31, 2018 | 189.24M |
| December 31, 2017 | 76.19M |
| September 30, 2017 | 35.44M |
| December 31, 2016 | 40.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
40.52M
Minimum
Sep 2020
285.28M
Maximum
Mar 2021
176.40M
Average
184.73M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 3.224B |
| PTC Therapeutics Inc | 1.790B |
| Capricor Therapeutics Inc | 49.44M |
| Catalyst Pharmaceuticals Inc | 646.68M |
| Pfizer Inc | 221.10B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.46M |
| Shareholders Equity (Quarterly) | 126.48M |